Last viewed:
POAI
Prices are updated after-hours
POAI
|
$0.4261
-3.12%
7.96%
|
|
Health Technology
(0.0% 1d)
(16.3% 1m)
(-67.5% 1y)
(0.0% 2d)
(-3.1% 3d)
(2.3% 7d)
(-0.91%
volume)
Earnings Calendar:
http://www.precisiontherapeutics.com
Sec
Filling
|
Patents
| 32 employees
(US) Predictive Oncology, Inc. engages in the application of artificial intelligence medicine business and provision of cleared STREAMWAY System for automated, direct-to-drain medical fluid disposal and associated products. It operates through the following segments: Domestic, International, and Helomics. The Domestic and International segments focuses on STREAMWAY System product sales. The Helomics segment comprises of clinical testing and contract research. The company was founded by Lawrence W. Gadbaw, Peter L. Morawetz, and Jeffrey K. Drogue on April 23, 2002 and is headquartered in Eagan, MN.
artificial intelligence
add to watch list
email alert is off
Price chart
% (High / Open) change chart
Press-releases
Predictive Oncology Announces Closing of $7.2 Million Registered Direct Offerings
Published: 2022-05-18
(Crawled : 22:00)
- globenewswire.com
POAI
|
$0.4261
-3.12%
7.96%
|
|
Health Technology
| 26.85%
| O: 1.31%
H: 0.5%
C: -10.34%
Predictive Oncology Announces $7.2 Million Registered Direct Offerings
Published: 2022-05-16
(Crawled : 13:00)
- globenewswire.com
POAI
|
$0.4261
-3.12%
7.96%
|
|
Health Technology
| -42.04%
| O: -45.29%
H: 1.72%
C: -5.84%
Predictive Oncology Reports First Quarter Financial Results
Published: 2022-05-12
(Crawled : 00:00)
- biospace.com/
POAI
|
$0.4261
-3.12%
7.96%
|
|
Health Technology
| -40.08%
| O: -2.8%
H: 0.0%
C: 0.0%
results
Marketer with over 20 years of experience selected to head up marketing at Predictive Oncology
Published: 2022-04-26
(Crawled : 18:00)
- globenewswire.com
POAI
|
$0.4261
-3.12%
7.96%
|
|
Health Technology
| -39.38%
| O: 5.28%
H: 1.35%
C: -5.14%
POAI Reports Strong Results From Its AI Cancer Drug Evaluation
Published: 2022-01-13
(Crawled : 14:30)
- biospace.com/
POAI
|
$0.4261
-3.12%
7.96%
|
|
Health Technology
| -56.07%
| O: 3.09%
H: 2.0%
C: -7.5%
strong result
drug
cancer drug
results
cancer
Predictive Oncology Adjourns Annual Meeting of Stockholders to December 30, 2021
Published: 2021-12-27
(Crawled : 23:00)
- globenewswire.com
POAI
|
$0.4261
-3.12%
7.96%
|
|
Health Technology
| -56.7%
| O: 1.27%
H: 0.35%
C: -0.05%
ORGS
4
|
$2.44
-1.21%
0.0%
|
|
Health Technology
| -15.28%
| O: 0.0%
H: 2.08%
C: -3.82%
Predictive Oncology – Year-end Shareholder Update!
Published: 2021-12-21
(Crawled : 01:00)
- globenewswire.com
POAI
|
$0.4261
-3.12%
7.96%
|
|
Health Technology
| -55.61%
| O: -0.78%
H: 7.09%
C: 6.04%
Pamela Bush, Ph.D., MBA, Joins Predictive Oncology as SVP of Strategic Sales and Business Development
Published: 2021-12-07
(Crawled : 14:00)
- globenewswire.com
POAI
|
$0.4261
-3.12%
7.96%
|
|
Health Technology
| -49.87%
| O: 16.47%
H: 5.05%
C: 2.02%
sales
Predictive Oncology Acquires zPREDICTA, Inc.
Published: 2021-12-01
(Crawled : 13:30)
- globenewswire.com
POAI
|
$0.4261
-3.12%
7.96%
|
|
Health Technology
| -58.83%
| O: 1.45%
H: 3.81%
C: -0.95%
Predictive Oncology Reports Third Quarter Financial Results
Published: 2021-11-10
(Crawled : 00:00)
- globenewswire.com
POAI
|
$0.4261
-3.12%
7.96%
|
|
Health Technology
| -63.11%
| O: 0.43%
H: 1.72%
C: -2.59%
financial results
results
See all
Last 15 days Sec forms
File Id
Form
Published Date
Transaction Date
Direction
Code
Amount Transacted
Owned Amount
0001415889-22-005765
4
2022-05-27
2022-05-26
Buy
P
2550
49666